Soya lecithin neutralizes quaternary ammonium compounds (QACs) like benzalkonium chloride by binding to their cationic sites, inactivating their antimicrobial activity. Tween 80 (polysorbate 80) is a non-ionic surfactant that neutralizes phenolic compounds and helps disperse lipophilic antimicrobials. Together they provide broad-spectrum neutralization while maintaining FTM's ability to support growth of test organisms. Effectiveness must be validated per USP <71> for each specific product and preservative combination.
Products requiring neutralizing FTM include: (1) Multi-dose injectables with preservatives (benzalkonium chloride, phenol, cresol), (2) Ophthalmic solutions with BAK or other preservatives, (3) Nasal sprays and inhalation products, (4) Topical pharmaceuticals with antimicrobial agents, (5) Disinfectants and antiseptics for sterility verification, (6) Any product where standard FTM validation shows preservative interference. USP <71> requires demonstrating preservative neutralization.
LQ270C3 is 300 ml RTU media, contains Fluid Thioglycollate Medium supplemented with 0.5% soya lecithin and 4% Tween 80 (polysorbate 80). These neutralizing agents inactivate quaternary ammonium compounds (benzalkonium chloride), phenolics, and other antimicrobial preservatives commonly found in pharmaceutical products. Essential for sterility testing of preserved products where standard FTM would give false-positive results due to preservative carryover inhibiting microbial growth.
HiMedia provides: (1) Certificate of Analysis (COA) for each lot with QC test results, (2) Technical Data Sheet with formulation and specifications, (3) Growth promotion data with ATCC reference strains, (4) Manufacturing process documentation, (5) ISO 13485 certification, (6) Plant-based peptone source documentation, (7) Comparative performance studies vs traditional media, (8) Regulatory compliance letters. Custom validation support available for pharmaceutical applications.
HiVeg media are particularly popular in: (1) India and Asian markets with cultural preferences for plant-based products, (2) European pharmaceutical manufacturers complying with strict BSE/TSE regulations, (3) Halal and Kosher certified pharmaceutical facilities, (4) Companies with animal-free policies, (5) Manufacturers of vegan/vegetarian therapeutic products, (6) Facilities seeking to eliminate animal product traceability requirements. Growing adoption in US GMP facilities seeking reproducibility improvements.
Yes, any media change requires revalidation per USP <71> Section 4.2. Perform: (1) Growth promotion testing with all required ATCC strains, (2) Sterility testing of media lots, (3) Method suitability testing with your specific products, (4) Side-by-side comparison with current media (recommended). While HiVeg® performance is equivalent, regulatory compliance requires validation for your specific application. HiMedia provides validation support documentation and Certificates of Analysis to assist.
Yes, HiVeg® FTM is performance-validated to meet the same USP <71> specifications as standard FTM. Growth promotion tests with ATCC reference strains (Clostridium sporogenes, Bacteroides vulgatus, Bacteroides fragilis, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis, Candida albicans) demonstrate equivalent or superior growth. pH, appearance, and sterility specifications are identical. Many pharmaceutical QC labs have successfully validated HiVeg as a direct replacement for traditional FTM.
HiVeg® media advantages: (1) No BSE/TSE risk from animal-derived ingredients, (2) Reduced batch-to-batch variability from plant sources, (3) Consistent nutritional composition, (4) Suitable for vegan/vegetarian animal free product manufacturing, (5) Improved regulatory compliance in markets restricting animal products, (6) Better lot-to-lot reproducibility. Performance matches or exceeds traditional formulations in supporting microbial growth for all USP <71> test organisms.
MV009 Fluid Thioglycollate HiVeg® Medium is an animal-free formulation using plant-based peptones instead of traditional casein and meat peptones. It maintains identical performance to standard FTM for USP <71> sterility testing while eliminating BSE/TSE risk. HiVeg® media offer consistent batch-to-batch performance, reduced variability, and support for vegan-friendly pharmaceutical manufacturing. Meets all USP, EP, and JP specifications.
Proteus species (P. mirabilis, P. vulgaris) produce urease and exhibit characteristic swarming motility on standard agar - rapidly spreading thin film that can cover entire plate obscuring other colonies. Crystal violet inhibits this swarming by: (1) Interfering with flagellar function, (2) Partially inhibiting growth rate, (3) Disrupting cell membrane processes. On MacConkey with increased crystal violet, Proteus produces discrete non-swarming colonies instead of spreading growth. This allows identification of other organisms (E. coli, Salmonella, Klebsiella) that would otherwise be obscured. Critical for clinical urine cultures where Proteus common.
MacConkey Agar with Crystal Violet has increased crystal violet concentration for enhanced selectivity against gram-positive bacteria and swarming of Proteus species. Standard MacConkey contains 1mg/L crystal violet; this formulation has higher amounts. Benefits: (1) Better inhibition of gram-positives (especially from heavily contaminated samples), (2) Prevents Proteus swarming (which can obscure other colonies), (3) Cleaner plates for colony picking. Use when: heavy gram-positive contamination expected, Proteus swarming is problem, pharmaceutical/clinical samples. May slightly reduce recovery of some sensitive gram-negatives.
MacConkey No.3 (less selective) - use for: clinical specimens (especially with antibiotic therapy), pharmaceutical EM, stressed organisms, maximum recovery priority. Regular MacConkey (more selective) - use for: food testing, water coliforms, routine screening, when selectivity needed against gram-positives. No.3 may allow some gram-positive breakthrough but recovers more gram-negatives. For regulatory testing, check method specifications - many require standard MacConkey. No.3 beneficial when recovery of all gram-negatives more important than complete inhibition of gram-positives.
MacConkey Agar No.3 is modified formulation with reduced crystal violet and bile salt concentrations compared to standard MacConkey. This less selective version improves recovery of stressed or injured gram-negative bacteria from clinical specimens and pharmaceutical samples. Still differentiates lactose fermenters (pink) from non-fermenters (colorless). Preferred when: (1) Testing clinical specimens with potential antibiotic therapy, (2) Pharmaceutical environmental monitoring (less harsh on environmental strains), (3) Water samples with stressed organisms. Use standard MacConkey for food/routine testing.
Blood Agar RTU plates: Store 2-8°C for 6-8 weeks typically. Check manufacturer COA for specific lot. Before use: (1) Equilibrate to room temperature, (2) Inspect for hemolysis (no spontaneous red color changes), (3) Check for contamination, (4) Verify no excessive moisture/drying. Blood plates have shorter shelf life than non-enriched agar due to RBC degradation. Older plates may show: reduced hemolysis clarity, decreased growth support, spontaneous greening. For critical clinical work, use plates within 2-4 weeks. Document receipt/expiration dates per QC SOPs.
Sheep blood is standard for Blood Agar because: (1) Safety - no human pathogens, (2) Hemolysis clarity - sheep RBCs show clearest beta-hemolysis (S. pyogenes, S. agalactiae), (3) NAD content - sheep blood lacks free NAD (V factor), preventing satellite phenomenon around Staphylococcus that could obscure Haemophilus detection, (4) Availability and cost, (5) Standardization - most reference methods specify sheep blood. Horse blood shows better Haemophilus growth but poorer hemolysis. Human blood has infection risk. Rabbit blood too expensive. Sheep optimal for routine clinical microbiology.
Plot No. C40, Road No. 21Y, MIDC, Wagle Industrial Estate, Thane(W)-400604, MH, India
